Search images on Google Product Monograph
Active Ingredients:
- bevacizumab, 400 MG/16 ML
DIN: 02522160
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINLGE-USE VIAL
Schedule: Prescription
Company: BIOSIMILAR COLLABORATIONS IRELAND LIMITED
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FG - (ATC, WHO)
- L01FG01 - BEVACIZUMAB (WHO)